Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?

BACKGROUND: Our previous work on early PSA kinetics following prostate stereotactic body radiation therapy (SBRT) demonstrated that an initial rapid and then slow PSA decline may result in very low PSA nadirs. This retrospective study sought to evaluate the PSA nadir 5 years following SBRT for low-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Kataria, Shaan, Koneru, Harsha, Guleria, Shan, Danner, Malika, Ayoob, Marilyn, Yung, Thomas, Lei, Siyuan, Collins, Brian T., Suy, Simeng, Lynch, John H., Kole, Thomas, Collins, Sean P.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522851/
https://ncbi.nlm.nih.gov/pubmed/28791252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00157
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados